Skip to main content
. 2013 Aug 22;53(2):102–107. doi: 10.3164/jcbn.13-37

Table 5.

The change of concentrations of Bone metabolic markers in serum

Group Ca (mmol/L) P (mmol/L) ALP (IU/L)
Group I (n = 37) Before taking isoflavone 2.33 ± 0.10 0.95 ± 0.14 59.37 ± 18.66
After taking isoflavone 2.53 ± 0.16* 0.94 ± 0.14 53.9 ± 13.76*
Group II (n = 33) Before taking isoflavone 2.30 ± 0.09 0.97 ± 0.12 57.37 ± 18.18
After taking isoflavone 2.39 ± 0.10* 0.98 ± 0.11 56.53 ± 18.85

Concentrations of bone metabolic markers in serum of subjects in isoflavone group and placebo group after 6 months of treatment with soy isoflavone 90 mg/day. Experimental conditions and treatment procedures are given in Materials and Methods. Graph depicts (mean ± SD). Asterisk means significant against baseline before trial (*p<0.05), t test.